Medicare Part D Premiums Expected to Spike 50%

Medicare Part D premiums are projected to increase by an average of 50% next year, according to findings from the Kaiser Family Foundation (KFF). This significant rise in premiums may lead seniors to reassess their prescription drug coverage options during the Medicare open enrollment period. The KFF has advised seniors to shop carefully, as there is a wide variance in costs between different plans.

This increase in premiums could have implications for pharmaceutical companies and drug manufacturers, as higher costs may affect patient access to medications and overall market dynamics. Stakeholders in the pharmaceutical supply chain may need to consider these changes when strategizing for the upcoming year.

Source: biopharmadive.com · Image: Teva Pharmaceutical Industries, Ontario, Canada (CC0)